Sab Biotherapeutics Inc (SABS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34,105 | -42,194 | -18,741 | -17,145 | 20,118 |
| Depreciation Amortization | 4,556 | 3,745 | 3,292 | 1,654 | 548 |
| Accounts receivable | N/A | 5,557 | 2,454 | 12,559 | -17,751 |
| Accounts payable and accrued liabilities | 923 | -2,702 | -779 | -2,936 | 5,212 |
| Other Working Capital | -2,299 | 2,326 | -238 | 11,683 | -11,954 |
| Other Operating Activity | -3,367 | 8,148 | -9,448 | -3,829 | 13,832 |
| Operating Cash Flow | $-34,292 | $-25,119 | $-23,460 | $1,987 | $10,005 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -337 | -153 | -2,090 | -10,944 | -12,723 |
| Purchase Of Investment | -37,446 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 25,821 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-11,962 | $-153 | $-2,090 | $-10,944 | $-12,723 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 516 | 765 | 1,236 | 2,841 | N/A |
| Debt Repayment | -132 | -127 | -161 | -1,296 | -182 |
| Common Stock Issued | 20 | 67,164 | 7,758 | 7 | 9,900 |
| Other Financing Activity | -1,577 | -1,029 | -7,781 | 34,340 | -736 |
| Financing Cash Flow | $-1,173 | $66,773 | $1,051 | $35,891 | $8,982 |
| Exchange Rate Effect | -241 | 18 | N/A | N/A | N/A |
| Beginning Cash Position | 56,566 | 15,047 | 39,545 | 12,610 | 6,346 |
| End Cash Position | 8,898 | 56,566 | 15,047 | 39,545 | 12,610 |
| Net Cash Flow | $-47,668 | $41,519 | $-24,498 | $26,935 | $6,264 |
| Free Cash Flow | |||||
| Operating Cash Flow | -34,292 | -25,119 | -23,460 | 1,987 | 10,005 |
| Capital Expenditure | -337 | -197 | -2,166 | -10,944 | -12,732 |
| Free Cash Flow | -34,629 | -25,317 | -25,626 | -8,957 | -2,727 |